|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Arnold M, Ferlay J, van Berge Henegouwen
MI and Soerjomataram I: Global burden of oesophageal and gastric
cancer by histology and subsite in 2018. Gut. 69:1564–1571.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhao Y, Zhang J, Cheng ASL, Yu J, To KF
and Kang W: Gastric cancer: Genome damaged by bugs. Oncogene.
39:3427–3442. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee JH, Son SY, Lee CM, Ahn SH, Park DJ
and Kim HH: Factors predicting peritoneal recurrence in advanced
gastric cancer: Implication for adjuvant intraperitoneal
chemotherapy. Gastric Cancer. 17:529–536. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thomassen I, van Gestel YR, van Ramshorst
B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE and de Hingh IH:
Peritoneal carcinomatosis of gastric origin: A population-based
study on incidence, survival and risk factors. Int J Cancer.
134:622–628. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Baghban R, Roshangar L, Jahanban-Esfahlan
R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T and
Zare P: Tumor microenvironment complexity and therapeutic
implications at a glance. Cell Commun Signal. 18(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu T, Han C, Wang S, Fang P, Ma Z, Xu L
and Yin R: Cancer-associated fibroblasts: An emerging target of
anti-cancer immunotherapy. J Hematol Oncol. 12(86)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sahai E, Astsaturov I, Cukierman E,
DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR,
Hunter T, et al: A framework for advancing our understanding of
cancer-associated fibroblasts. Nat Rev Cancer. 20:174–186.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hanley CJ and Thomas GJ: Targeting cancer
associated fibroblasts to enhance immunotherapy: Emerging
strategies and future perspectives. Oncotarget. 12:1427–1433.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Santana-Viera L, Ibba ML, Rotoli D,
Catuogno S and Esposito CL: Emerging therapeutic RNAs for the
targeting of cancer associated fibroblasts. Cancers (Basel).
12(1365)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu X, Yao L, Qu J, Liu L, Lu N, Wang J
and Zhang J: Cancer-associated fibroblast infiltration in gastric
cancer: The discrepancy in subtypes pathways and immunosuppression.
J Transl Med. 19(325)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ham IH, Lee D and Hur H: Role of
cancer-associated fibroblast in gastric cancer progression and
resistance to treatments. J Oncol. 2019(6270784)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qin Y, Wang F, Ni H, Liu Y, Yin Y, Zhou X,
Gao G, Li Q, Qi X and Li J: Cancer-associated fibroblasts in
gastric cancer affect malignant progression via the CXCL12-CXCR4
axis. J Cancer. 12:3011–3023. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X,
Li J, Li C, Yan M, Zhu Z, et al: IL-6 secreted by cancer-associated
fibroblasts promotes epithelial-mesenchymal transition and
metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Oncotarget. 8:20741–20750. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang J, Li S, Zhao Y, Ma P, Cao Y, Liu C,
Zhang X, Wang W, Chen L and Li Y: Cancer-associated fibroblasts
promote the migration and invasion of gastric cancer cells via
activating IL-17a/JAK2/STAT3 signaling. Ann Transl Med.
8(877)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tang D, Gao J, Wang S, Ye N, Chong Y,
Huang Y, Wang J, Li B, Yin W and Wang D: Cancer-associated
fibroblasts promote angiogenesis in gastric cancer through
galectin-1 expression. Tumour Biol. 37:1889–1899. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ding X, Xi W, Ji J, Cai Q, Jiang J, Shi M,
Yu Y, Zhu Z and Zhang J: HGF derived from cancer-associated
fibroblasts promotes vascularization in gastric cancer via PI3K/AKT
and ERK1/2 signaling. Oncol Rep. 40:1185–1195. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ma J, Song X, Xu X and Mou Y:
Cancer-associated fibroblasts promote the chemo-resistance in
gastric cancer through secreting IL-11 targeting JAK/STAT3/Bcl2
pathway. Cancer Res Treat. 51:194–210. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ham IH, Oh HJ, Jin H, Bae CA, Jeon SM,
Choi KS, Son SY, Han SU, Brekken RA, Lee D and Hur H: Targeting
interleukin-6 as a strategy to overcome stroma-induced resistance
to chemotherapy in gastric cancer. Mol Cancer.
18(68)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Uchihara T, Miyake K, Yonemura A, Komohara
Y, Itoyama R, Koiwa M, Yasuda T, Arima K, Harada K, Eto K, et al:
Extracellular vesicles from cancer-associated fibroblasts
containing annexin A6 induces FAK-YAP activation by stabilizing β1
integrin, enhancing drug resistance. Cancer Res. 80:3222–3235.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hu J, Ma Y, Ma J, Yang Y, Ning Y, Zhu J,
Wang P, Chen G and Liu Y: M2 Macrophage-based prognostic nomogram
for gastric cancer after surgical resection. Front Oncol.
11(690037)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gambardella V, Castillo J, Tarazona N,
Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló
S, Roda D, Huerta M, Cervantes A and Fleitas T: The role of
tumor-associated macrophages in gastric cancer development and
their potential as a therapeutic target. Cancer Treat Rev.
86(102015)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen B, Chan WN, Xie F, Mui CW, Liu X,
Cheung AHK, Lung RWM, Chow C, Zhang Z, Fang C, et al: The molecular
classification of cancer-associated fibroblasts on a pan-cancer
single-cell transcriptional atlas. Clin Transl Med.
13(e1516)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sathe A, Grimes SM, Lau BT, Chen J, Suarez
C, Huang RJ, Poultsides G and Ji HP: Single-cell genomic
characterization reveals the cellular reprogramming of the gastric
tumor microenvironment. Clin Cancer Res. 26:2640–2653.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kudo A: Periostin in fibrillogenesis for
tissue regeneration: Periostin actions inside and outside the cell.
Cell Mol Life Sci. 68:3201–3207. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kruzynska-Frejtag A, Machnicki M, Rogers
R, Markwald RR and Conway SJ: Periostin (an osteoblast-specific
factor) is expressed within the embryonic mouse heart during valve
formation. Mech Dev. 103:183–188. 2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dorafshan S, Razmi M, Safaei S, Gentilin
E, Madjd Z and Ghods R: Periostin: Biology and function in cancer.
Cancer Cell Int. 22(315)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339.
2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yan W and Shao R: Transduction of a
mesenchyme-specific gene periostin into 293T cells induces cell
invasive activity through epithelial-mesenchymal transformation. J
Biol Chem. 281:19700–19708. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hong L, Sun H, Lv X, Yang D, Zhang J and
Shi Y: Expression of periostin in the serum of NSCLC and its
function on proliferation and migration of human lung
adenocarcinoma cell line (A549) in vitro. Mol Biol Rep.
37:2285–2293. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhao Z, Mak TK, Shi Y, Li K, Huo M and
Zhang C: Integrative analysis of cancer-associated fibroblast
signature in gastric cancer. Heliyon. 9(e19217)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nikoloudaki G, Snider P, Simmons O, Conway
SJ and Hamilton DW: Periostin and matrix stiffness combine to
regulate myofibroblast differentiation and fibronectin synthesis
during palatal healing. Matrix Biol. 94:31–56. 2020.PubMed/NCBI View Article : Google Scholar
|
